{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:21Z","timestamp":1792784841506,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"40","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA244900"],"award-info":[{"award-number":["R01 CA244900"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA036727"],"award-info":[{"award-number":["P30 CA036727"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA009467"],"award-info":[{"award-number":["T32 CA009467"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM121316"],"award-info":[{"award-number":["P20 GM121316"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural Research Programs of the National Human Genome Research Institute, National Institutes of Health.","id":[{"id":"https:\/\/ror.org\/00baak391","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,10,20]]},"DOI":"10.1038\/s41388-026-03956-w","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:09:02Z","timestamp":1786936142000},"page":"4317-4329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Inv(16) Oncogene CBFB::MYH11 is Required for the Survival of Leukemia Cells in the Blood and Spleen, but not the Bone Marrow"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7145-6273","authenticated-orcid":false,"given":"Sipra","family":"Panda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatasai Rahul","family":"Dogiparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Dhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemlem","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5650-3841","authenticated-orcid":false,"given":"Samantha A.","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle J.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2808-1749","authenticated-orcid":false,"given":"R. Katherine","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"3956_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02376-5","volume":"9","author":"O Akinduro","year":"2018","unstructured":"Akinduro O, Weber TS, Ang H, Haltalli MLR, Ruivo N, Duarte D, et al. Proliferation dynamics of acute myeloid leukaemia and haematopoietic progenitors competing for bone marrow space. Nat Commun. 2018;9:519.","journal-title":"Nat Commun"},{"key":"3956_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"D Thomas","year":"2017","unstructured":"Thomas D, Majeti R. Biology and relevance of human acute myeloid leukemia stem cells. Blood. 2017;129:1577\u201385.","journal-title":"Blood"},{"key":"3956_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1182\/blood-2009-01-202606","volume":"114","author":"SW Lane","year":"2009","unstructured":"Lane SW, Scadden DT, Gilliland DG. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood. 2009;114:1150\u20137.","journal-title":"Blood"},{"key":"3956_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1947601911408076","volume":"2","author":"CC Kumar","year":"2011","unstructured":"Kumar CC. Genetic abnormalities and challenges in the treatment of acute myeloid leukemia. Genes Cancer. 2011;2:95\u2013107.","journal-title":"Genes Cancer"},{"key":"3956_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc840","volume":"2","author":"NA Speck","year":"2002","unstructured":"Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer. 2002;2:502\u201313.","journal-title":"Nat Rev Cancer"},{"key":"3956_CR6","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1073\/pnas.0400930101","volume":"101","author":"LH Castilla","year":"2004","unstructured":"Castilla LH, Perrat P, Martinez NJ, Landrette SF, Keys R, Oikemus S, et al. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proc Natl Acad Sci USA. 2004;101:4924\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3956_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/leu.2015.141","volume":"30","author":"R Sood","year":"2016","unstructured":"Sood R, Hansen NF, Donovan FX, Carrington B, Bucci D, Maskeri B, et al. Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia. Leukemia. 2016;30:501\u20134.","journal-title":"Leukemia"},{"key":"3956_CR8","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2015-12-688705","volume":"127","author":"N Duployez","year":"2016","unstructured":"Duployez N, Marceau-Renaut A, Boissel N, Petit A, Bucci M, Geffroy S, et al. Comprehensive mutational profiling of core binding factor acute myeloid leukemia. Blood. 2016;127:2451\u20139.","journal-title":"Blood"},{"key":"3956_CR9","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36:1703\u201319.","journal-title":"Leukemia"},{"key":"3956_CR10","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3324\/haematol.2010.038976","volume":"96","author":"BV Balgobind","year":"2011","unstructured":"Balgobind BV, Hollink IH, Arentsen-Peters ST, Zimmermann M, Harbott J, Beverloo HB, et al. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia. Haematologica. 2011;96:1478\u201387.","journal-title":"Haematologica"},{"key":"3956_CR11","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/leu.2014.55","volume":"28","author":"R Kihara","year":"2014","unstructured":"Kihara R, Nagata Y, Kiyoi H, Kato T, Yamamoto E, Suzuki K, et al. Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients. Leukemia. 2014;28:1586\u201395.","journal-title":"Leukemia"},{"key":"3956_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/sj.leu.2401678","volume":"14","author":"M Mancini","year":"2000","unstructured":"Mancini M, Cedrone M, Diverio D, Emanuel B, Stul M, Vranckx H, et al. Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients. Leukemia. 2000;14:364\u20138.","journal-title":"Leukemia"},{"key":"3956_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00062752-200107000-00004","volume":"8","author":"M Kundu","year":"2001","unstructured":"Kundu M, Liu PP. Function of the inv(16) fusion gene CBFB-MYH11. Curr Opin Hematol. 2001;8:201\u20135.","journal-title":"Curr Opin Hematol"},{"key":"3956_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1126\/science.8351518","volume":"261","author":"P Liu","year":"1993","unstructured":"Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, et al. Fusion between transcription factor CBF beta\/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science. 1993;261:1041\u20134.","journal-title":"Science"},{"key":"3956_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/(SICI)1098-2264(199606)16:2<77::AID-GCC1>3.0.CO;2-#","volume":"16","author":"PP Liu","year":"1996","unstructured":"Liu PP, Wijmenga C, Hajra A, Blake TB, Kelley CA, Adelstein RS, et al. Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells. Genes Chromosomes Cancer. 1996;16:77\u201387.","journal-title":"Genes Chromosomes Cancer"},{"key":"3956_CR16","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1200\/JCO.2005.15.610","volume":"23","author":"G Marcucci","year":"2005","unstructured":"Marcucci G, Mrozek K, Ruppert AS, Maharry K, Kolitz JE, Moore JO, et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol. 2005;23:5705\u201317.","journal-title":"J Clin Oncol"},{"key":"3956_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2141.2006.06276.x","volume":"135","author":"FR Appelbaum","year":"2006","unstructured":"Appelbaum FR, Kopecky KJ, Tallman MS, Slovak ML, Gundacker HM, Kim HT, et al. The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations. Br J Haematol. 2006;135:165\u201373.","journal-title":"Br J Haematol"},{"key":"3956_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccr.2005.12.014","volume":"9","author":"YH Kuo","year":"2006","unstructured":"Kuo YH, Landrette SF, Heilman SA, Perrat PN, Garrett L, Liu PP, et al. Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell. 2006;9:57\u201368.","journal-title":"Cancer Cell"},{"key":"3956_CR19","doi-asserted-by":"crossref","unstructured":"Mandoli A, Singh AA, Jansen PW, Wierenga AT, Riahi H, Franci G, et al. CBFB-MYH11\/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia. Leukemia. 2014;28:770\u20138.","DOI":"10.1038\/leu.2013.257"},{"key":"3956_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38408-3","volume":"9","author":"Y Wang","year":"2019","unstructured":"Wang Y, Richter L, Becker M, Amador C, Hyde RK. IL1RL1 is dynamically expressed on Cbfb-MYH11+ leukemia stem cells and promotes cell survival. Sci Rep. 2019;9:1729.","journal-title":"Sci Rep"},{"key":"3956_CR21","doi-asserted-by":"crossref","unstructured":"Richter LE, Wang Y, Becker ME, Coburn RA, Williams JT, Amador C, et al. HDAC1 is a required cofactor of CBFbeta-SMMHC and a potential therapeutic target in inversion 16 acute myeloid leukemia. Mol Cancer Res. 2019:17:1241\u201352.","DOI":"10.1158\/1541-7786.MCR-18-0922"},{"key":"3956_CR22","doi-asserted-by":"crossref","unstructured":"Dhir A, Ethell A, Watkins R, Lam C, Tur-Rodriguez K, Persinger J, et al. The splicing factor PTBP1 interacts with RUNX1 and is required for leukemia cell survival. Leukemia. 2026;40:135\u201351.","DOI":"10.1038\/s41375-025-02799-w"},{"key":"3956_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0092-8674(00)81388-4","volume":"87","author":"LH Castilla","year":"1996","unstructured":"Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, et al. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell. 1996;87:687\u201396.","journal-title":"Cell"},{"key":"3956_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ccr.2010.03.022","volume":"17","author":"Y Kamikubo","year":"2010","unstructured":"Kamikubo Y, Zhao L, Wunderlich M, Corpora T, Hyde RK, Paul TA, et al. Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1. Cancer Cell. 2010;17:455\u201368.","journal-title":"Cancer Cell"},{"key":"3956_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1101\/SQB.1997.062.01.021","volume":"62","author":"M Lewandoski","year":"1997","unstructured":"Lewandoski M, Meyers EN, Martin GR. Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb Symp Quant Biol. 1997;62:159\u201368.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"3956_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/13776","volume":"23","author":"LH Castilla","year":"1999","unstructured":"Castilla LH, Garrett L, Adya N, Orlic D, Dutra A, Anderson S, et al. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia [letter]. Nat Genet. 1999;23:144\u20136.","journal-title":"Nat Genet"},{"key":"3956_CR27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood-2012-06-434688","volume":"121","author":"Y Kamikubo","year":"2013","unstructured":"Kamikubo Y, Hyde RK, Zhao L, Alemu L, Rivas C, Garrett LJ, et al. The C-terminus of CBFbeta-SMMHC is required to induce embryonic hematopoietic defects and leukemogenesis. Blood. 2013;121:638\u201342.","journal-title":"Blood"},{"key":"3956_CR28","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/leu.2015.58","volume":"29","author":"RK Hyde","year":"2015","unstructured":"Hyde RK, Zhao L, Alemu L, Liu PP. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice. Leukemia. 2015;29:1771\u20138.","journal-title":"Leukemia"},{"key":"3956_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nmeth.4179","volume":"14","author":"TM Gierahn","year":"2017","unstructured":"Gierahn TM, Wadsworth MH 2nd, Hughes TK, Bryson BD, Butler A, et al. Seq-well: portable, low-cost RNA sequencing of single cells at high throughput. Nat Methods. 2017;14:395\u20138.","journal-title":"Nat Methods"},{"key":"3956_CR30","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1182\/bloodadvances.2022009163","volume":"7","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Dogiparthi VR, Ray S, Schaefer MA, Harris HL, Rowley MJ, et al. Defining a cohort of anemia-activated cis elements reveals a mechanism promoting erythroid precursor function. Blood Adv. 2023;7:6325\u201338.","journal-title":"Blood Adv"},{"key":"3956_CR31","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1182\/blood-2009-06-227413","volume":"115","author":"RK Hyde","year":"2010","unstructured":"Hyde RK, Kamikubo Y, Anderson S, Kirby M, Alemu L, Zhao L, et al. Cbfb\/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11. Blood. 2010;115:1433\u201343.","journal-title":"Blood"},{"key":"3956_CR32","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41375-023-01926-9","volume":"37","author":"JL Diemer","year":"2023","unstructured":"Diemer JL, Yu K, Kelly M, Zhen T, Anderson S, Lopez G, et al. Characterization of leukemia progression in the Cbfb-MYH11 knockin mice by single cell RNA sequencing. Leukemia. 2023;37:1549\u201353.","journal-title":"Leukemia"},{"key":"3956_CR33","doi-asserted-by":"crossref","unstructured":"Arnone M, Konantz M, Hanns P, Paczulla Stanger AM, Bertels S, Godavarthy PS, et al. Acute myeloid leukemia stem cells: the challenges of phenotypic heterogeneity. Cancers (Basel). 2020;12:3742.","DOI":"10.3390\/cancers12123742"},{"key":"3956_CR34","doi-asserted-by":"publisher","first-page":"e1200778","DOI":"10.1080\/2162402X.2016.1200778","volume":"5","author":"J Li","year":"2016","unstructured":"Li J, Shayan G, Avery L, Jie HB, Gildener-Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3(+) T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778.","journal-title":"Oncoimmunology"},{"key":"3956_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.stem.2015.08.019","volume":"17","author":"Y Saito","year":"2015","unstructured":"Saito Y, Chapple RH, Lin A, Kitano A, Nakada D. AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the Bone Marrow. Cell Stem Cell. 2015;17:585\u201396.","journal-title":"Cell Stem Cell"},{"key":"3956_CR36","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/2159-8290.CD-22-0601","volume":"13","author":"C Glytsou","year":"2023","unstructured":"Glytsou C, Chen X, Zacharioudakis E, Al-Santli W, Zhou H, Nadorp B, et al. Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia. Cancer Discov. 2023;13:1656\u201377.","journal-title":"Cancer Discov"},{"key":"3956_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41420-024-01823-9","volume":"10","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen J, Zou Z, Xu L, Li J. Crosstalk between autophagy and metabolism: implications for cell survival in acute myeloid leukemia. Cell Death Discov. 2024;10:46.","journal-title":"Cell Death Discov"},{"key":"3956_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189214","volume":"1879","author":"BG Santos de Macedo","year":"2024","unstructured":"Santos de Macedo BG, Albuquerque de Melo M, Pereira-Martins DA, Machado-Neto JA, Traina F. An updated outlook on autophagy mechanism and how it supports acute myeloid leukemia maintenance. Biochim Biophys Acta Rev Cancer. 2024;1879:189214.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3956_CR39","doi-asserted-by":"crossref","unstructured":"Nepstad I, Hatfield KJ, Gronningsaeter IS, Reikvam H. The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells. Int J Mol Sci. 2020;21:2907.","DOI":"10.3390\/ijms21082907"},{"key":"3956_CR40","doi-asserted-by":"publisher","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","volume":"44","author":"FO Bagger","year":"2016","unstructured":"Bagger FO, Sasivarevic D, Sohi SH, Laursen LG, Pundhir S, Sonderby CK, et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 2016;44:D917\u201324.","journal-title":"Nucleic Acids Res"},{"key":"3956_CR41","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.3324\/haematol.2023.283757","volume":"109","author":"AJ Menssen","year":"2024","unstructured":"Menssen AJ, Hudson CA, Alonzo T, Gerbing R, Pardo L, Leonti A, et al. CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children\u2019s Oncology Group. Haematologica. 2024;109:3182\u201393.","journal-title":"Haematologica"},{"key":"3956_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41375-019-0596-4","volume":"34","author":"B Alanazi","year":"2020","unstructured":"Alanazi B, Munje CR, Rastogi N, Williamson AJK, Taylor S, Hole PS, et al. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. Leukemia. 2020;34:427\u201340.","journal-title":"Leukemia"},{"key":"3956_CR43","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/1878-0261.12640","volume":"14","author":"S Waldeck","year":"2020","unstructured":"Waldeck S, Rassner M, Keye P, Follo M, Herchenbach D, Endres C, et al. CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML. Mol Oncol. 2020;14:779\u201394.","journal-title":"Mol Oncol"},{"key":"3956_CR44","doi-asserted-by":"publisher","first-page":"qiaf072.","DOI":"10.1093\/jleuko\/qiaf072","volume":"117","author":"J Mou","year":"2025","unstructured":"Mou J, Huang Q, Liu X, Liu W, Liu Y, Mei Y. et al. AML1-ETO and CCND2 overexpression cooperate to drive acute myeloid leukemia initiation and progression. J Leukoc Biol. 2025;117:qiaf072.","journal-title":"J Leukoc Biol"},{"key":"3956_CR45","first-page":"149","volume":"341","author":"AO Kittang","year":"2010","unstructured":"Kittang AO, Hatfield K, Sand K, Reikvam H, Bruserud O. The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications. Curr Top Microbiol Immunol. 2010;341:149\u201372.","journal-title":"Curr Top Microbiol Immunol"},{"key":"3956_CR46","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1182\/blood-2007-02-073486","volume":"110","author":"BJ Wouters","year":"2007","unstructured":"Wouters BJ, Jord\u00e0 MA, Keeshan K, Louwers I, Erpelinck-Verschueren CA, Tielemans D, et al. Distinct gene expression profiles of acute myeloid\/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood. 2007;110:3706\u201314.","journal-title":"Blood"},{"key":"3956_CR47","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1182\/blood-2013-11-539049","volume":"123","author":"A Duckworth","year":"2014","unstructured":"Duckworth A, Glenn M, Slupsky JR, Packham G, Kalakonda N. Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy. Blood. 2014;123:3277\u201385.","journal-title":"Blood"},{"key":"3956_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101195","volume":"65","author":"DJ Fowler-Shorten","year":"2024","unstructured":"Fowler-Shorten DJ, Hellmich C, Markham M, Bowles KM, Rushworth SA. BCL-2 inhibition in haematological malignancies: Clinical application and complications. Blood Rev. 2024;65:101195.","journal-title":"Blood Rev"},{"key":"3956_CR49","doi-asserted-by":"crossref","unstructured":"Griffioen MS, de Leeuw DC, Janssen J, Smit L. Targeting acute myeloid leukemia with venetoclax; biomarkers for sensitivity and rationale for venetoclax-based combination therapies. Cancers (Basel). 2022;14:3456.","DOI":"10.3390\/cancers14143456"},{"key":"3956_CR50","first-page":"1529","volume":"11","author":"Y Lian","year":"2018","unstructured":"Lian Y, Xie Y, Hong M, Zhu Y, Zhao H, Zhao X, et al. Clinical significance of BECLIN1 and ATG5 expression in acute myeloid leukemia patients. Int J Clin Exp Pathol. 2018;11:1529\u201337.","journal-title":"Int J Clin Exp Pathol"},{"key":"3956_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-022-01262-y","volume":"15","author":"W Seo","year":"2022","unstructured":"Seo W, Silwal P, Song I-C, Jo E-K. The dual role of autophagy in acute myeloid leukemia. J Hematol Oncol. 2022;15:51.","journal-title":"J Hematol Oncol"},{"key":"3956_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-0885-0","volume":"22","author":"EE Ladikou","year":"2020","unstructured":"Ladikou EE, Sivaloganathan H, Pepper A, Chevassut T. Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia. Curr Oncol Rep. 2020;22:27.","journal-title":"Curr Oncol Rep"},{"key":"3956_CR53","doi-asserted-by":"crossref","unstructured":"Kuek V, Hughes AM, Kotecha RS, Cheung LC. Therapeutic targeting of the leukaemia microenvironment. Int J Mol Sci. 2021;22:6888.","DOI":"10.3390\/ijms22136888"},{"key":"3956_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jmb.2019.06.025","volume":"432","author":"SE Koschade","year":"2020","unstructured":"Koschade SE, Brandts CH. Selective autophagy in normal and malignant hematopoiesis. J Mol Biol. 2020;432:261\u201382.","journal-title":"J Mol Biol"},{"key":"3956_CR55","doi-asserted-by":"publisher","first-page":"21746","DOI":"10.1002\/jcp.28903","volume":"234","author":"S Shahrabi","year":"2019","unstructured":"Shahrabi S, Paridar M, Zeinvand-Lorestani M, Jalili A, Zibara K, Abdollahi M, et al. Autophagy regulation and its role in normal and malignant hematopoiesis. J Cell Physiol. 2019;234:21746\u201357.","journal-title":"J Cell Physiol"},{"key":"3956_CR56","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1182\/blood-2006-01-0177","volume":"108","author":"S Wei","year":"2006","unstructured":"Wei S, Kryczek I, Zou W. Regulatory T-cell compartmentalization and trafficking. Blood. 2006;108:426\u201331.","journal-title":"Blood"},{"key":"3956_CR57","first-page":"51","volume":"7","author":"F Di Rosa","year":"2016","unstructured":"Di Rosa F, Gebhardt T. Bone marrow T cells and the integrated functions of recirculating and tissue-resident memory T cells. Front Immunol. 2016;7:51.","journal-title":"Front Immunol"},{"key":"3956_CR58","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408\u201317.","journal-title":"N Engl J Med"},{"key":"3956_CR59","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1182\/blood-2010-03-273979","volume":"116","author":"TP Hughes","year":"2010","unstructured":"Hughes TP, Hochhaus A, Branford S, Muller MC, Kaeda JS, Foroni L, et al. Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS). Blood. 2010;116:3758\u201365.","journal-title":"Blood"},{"key":"3956_CR60","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41375-018-0252-4","volume":"33","author":"P Baquero","year":"2019","unstructured":"Baquero P, Dawson A, Mukhopadhyay A, Kuntz EM, Mitchell R, Olivares O, et al. Targeting quiescent leukemic stem cells using second generation autophagy inhibitors. Leukemia. 2019;33:981\u201394.","journal-title":"Leukemia"},{"key":"3956_CR61","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","volume":"119","author":"A Hamilton","year":"2012","unstructured":"Hamilton A, Helgason GV, Schemionek M, Zhang B, Myssina S, Allan EK, et al. Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival. Blood. 2012;119:1501\u201310.","journal-title":"Blood"},{"key":"3956_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.769730","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zou J, Cheng F, Li W. Treatment-free remission in chronic myeloid leukemia and new approaches by targeting leukemia stem cells. Front Oncol. 2021;11:769730.","journal-title":"Front Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03956-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03956-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03956-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:09:56Z","timestamp":1790168996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03956-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":62,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2026,10,20]]}},"alternative-id":["3956"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03956-w","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}